Day One Biopharmaceuticals, Inc.
NASDAQ:DAWN
12.79 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 422.765 | 239.616 | 270.391 | 230.784 | 241.179 | 189.211 | 49.268 | 85.262 | 120.864 | 388.877 | 262.731 | 284.309 | 297.16 | 309.996 | 154.87 | 43.728 | 0 |
Short Term Investments
| 135.618 | 122.25 | 47.553 | 135.563 | 164.359 | 253.671 | 268.911 | 257.007 | 253.477 | 5.987 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 558.383 | 361.866 | 317.944 | 366.347 | 405.538 | 442.882 | 318.179 | 342.269 | 374.341 | 394.864 | 262.731 | 284.309 | 297.16 | 309.996 | 154.87 | 43.728 | 27.332 |
Net Receivables
| 8.695 | 9.136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 2.735 | 0.151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 11.183 | 12.005 | 8.09 | 8.927 | 7.753 | 6.902 | 4.209 | 5.605 | 6.172 | 7.639 | 4.637 | 5.059 | 6.151 | 6.029 | 0.115 | 1.343 | 0 |
Total Current Assets
| 580.996 | 383.158 | 326.034 | 375.274 | 405.538 | 449.784 | 322.388 | 347.874 | 380.513 | 402.503 | 267.368 | 289.368 | 303.311 | 316.025 | 158.755 | 45.071 | 27.332 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 3.478 | 0.36 | 0.444 | 0.56 | 0.655 | 0.713 | 0.688 | 0.719 | 0.899 | 1.06 | 0.246 | 0.284 | 0.335 | 0.386 | 0.435 | 0.483 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 16.216 | 16.802 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 16.216 | 16.802 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.117 | 0.117 | 0.167 | 0.214 | 7.986 | 0.259 | 0.487 | 0.469 | 0.449 | 0.484 | 0.165 | 0.169 | 0.137 | 0.126 | 1.69 | 0.107 | -27.332 |
Total Non-Current Assets
| 19.811 | 17.279 | 0.611 | 0.774 | 8.641 | 0.972 | 1.175 | 1.188 | 1.348 | 1.544 | 0.411 | 0.453 | 0.472 | 0.512 | 2.125 | 0.59 | -27.332 |
Total Assets
| 600.807 | 400.437 | 326.645 | 376.048 | 414.179 | 450.756 | 323.563 | 349.062 | 381.861 | 404.047 | 267.779 | 289.821 | 303.783 | 316.537 | 160.88 | 45.661 | 0 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 3.017 | 6.444 | 4.78 | 2.576 | 3.391 | 4.565 | 4.657 | 0.26 | 3.973 | 0.439 | 0.701 | 1.744 | 0.683 | 0.348 | 0.686 | 0.202 | 0 |
Short Term Debt
| 0.154 | 0.38 | 0.3 | 0.816 | 0.874 | 0.856 | 0.834 | 0.405 | 0.924 | 0.854 | 0.342 | 0.204 | 0.404 | 0.402 | 0.199 | 0.198 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 1.462 | 0 | 0 | 25.483 | 20.238 | 19.333 | 0 | 0 | 0 | 11.772 | 0 | 6.605 | 4.976 | 4.019 | 2.174 | 1.569 | 0 |
Other Current Liabilities
| 35.112 | 86.882 | 24.759 | 26.116 | 20.21 | 19.091 | 17.357 | 15.95 | 13.374 | 11.506 | 7.133 | 6.709 | 4.959 | 3.912 | 2.181 | 1.596 | 0 |
Total Current Liabilities
| 39.745 | 93.706 | 29.839 | 29.508 | 24.475 | 24.512 | 22.848 | 16.615 | 18.271 | 12.799 | 8.176 | 8.657 | 6.046 | 4.662 | 3.066 | 1.996 | 0 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 2.538 | 0 | 0 | 0 | 0.077 | 0.19 | 0.3 | 0.408 | 0.514 | 0.617 | 0 | 0.016 | 0.065 | 0.112 | 0.159 | 0.204 | 0 |
Deferred Revenue Non-Current
| 3.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 221.721 | 91.964 | -25.318 |
Total Non-Current Liabilities
| 5.599 | 0 | 0 | 0 | 0.077 | 0.19 | 0.3 | 0.408 | 0.514 | 0.617 | 0.872 | 0.016 | 0.065 | 0.112 | 221.88 | 92.168 | -25.318 |
Total Liabilities
| 45.344 | 93.706 | 29.839 | 29.508 | 818.253 | 24.702 | 23.148 | 17.023 | 18.785 | 13.416 | 8.176 | 8.673 | 6.111 | 4.774 | 224.946 | 94.164 | -25.318 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 303.783 | 0 | 4.783 | 0 | 30.504 |
Common Stock
| 0.01 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.007 | 0.007 | 0.007 | 0.007 | 0.006 | 0.006 | 0.006 | 0.006 | 2 | 2 | 0 |
Retained Earnings
| -488.367 | -525.404 | -520.997 | -458.585 | -404.074 | -357.924 | -312.061 | -269.668 | -229.559 | -191.764 | -155.234 | -127.487 | -105.548 | -86.308 | -72.024 | -56.842 | 0 |
Accumulated Other Comprehensive Income/Loss
| -0.006 | -0.022 | -0.005 | 0.009 | -0.007 | -0.009 | 0.067 | -0.071 | -0.392 | -0.003 | 0 | 0 | -303.783 | 0 | 0 | 0 | -10.673 |
Other Total Stockholders Equity
| 1,043.826 | 832.148 | 817.799 | 805.107 | 793.699 | 783.978 | 612.402 | 601.771 | 593.02 | 582.391 | 414.831 | 408.629 | 706.997 | 398.065 | -3.608 | 92.601 | 5.487 |
Total Shareholders Equity
| 555.463 | 306.731 | 296.806 | 346.54 | -404.074 | 426.054 | -312.061 | 332.039 | 363.076 | 390.631 | 259.603 | -127.487 | 297.672 | 311.763 | -68.849 | -54.205 | 25.318 |
Total Equity
| 555.463 | 306.731 | 296.806 | 346.54 | -404.074 | 426.054 | -312.061 | 332.039 | 363.076 | 390.631 | 259.603 | 0 | 0 | 0 | 0 | 0 | 25.318 |
Total Liabilities & Shareholders Equity
| 600.807 | 400.437 | 326.645 | 376.048 | 414.179 | 450.756 | -288.913 | 349.062 | 381.861 | 404.047 | 267.779 | -118.814 | 303.783 | 316.537 | 160.88 | 45.661 | 0 |